Dual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneous coronary intervention: A meta-analysis
Conclusions:
DT with a NOAC and a P2Y12 inhibitor was associated with significantly less bleeding events without increasing the adverse cardiovascular outcomes when compared to TT with aspirin, a P2Y12 inhibitor and a Vitamin K antagonist for the treatment of DM patients with co-existing AF following PCI. Hence, DT is comparable in efficacy, but safer compared to TT. This interesting hypothesis will have to be confirmed in future studies.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
More News: Angioplasty | Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Coronary Angioplasty | Databases & Libraries | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Attack | Internal Medicine | Percutaneous Coronary Intervention | Science | Stroke | Study | Thrombosis | Vitamin K | Vitamins